Every patient is a unique individual, and Perthera recognizes that a patient’s cancer is just as unique as they are. Perthera’s Precision Medicine Management has the potential to bring highly effective therapies and high-value care to patients; it can also lower the overall cost of treating many different types of cancer.
Patients no longer have to rely on nonspecific, one size fits all, recommendations. The oncology patient is no longer “a male in his 50’s whose biopsy reveals non–small-cell lung cancer” and offered a treatment that only about 10% of patients respond to, with a negligible survival benefit and significant side effects.
Tailoring medical treatment to the patient’s distinct genetic characteristics can identify the best course of treatment and may even avoid or reduce adverse drug reactions along with the toxic effects of therapies that may not be necessary.